Dual-modified antisense oligonucleotides targeting oncogenic protocadherin to treat gastric cancer. Kanda M, Kasahara Y, Shimizu D, Shinozuka T, et al. Br J Cancer 2024 Sep 20. doi: 10.1038/s41416-024-02859.

Read + Share

Amedeo Smart

Independent Medical Education

Kanda M, Kasahara Y, Shimizu D, Shinozuka T, et al. Dual-modified antisense oligonucleotides targeting oncogenic protocadherin to treat gastric cancer. Br J Cancer 2024 Sep 20. doi: 10.1038/s41416-024-02859.
PMID: 39304746